DETROIT, Oct. 2 (HSMN NewsFeed) — Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro(R) (escitalopram oxalate) tablets, it closed an Asset …
Biopharmaceuticals, Litigation, Licensing
Caraco Clinical, Forest Laboratories, Lexapro, escitalopram

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Caraco Clinical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation”
Leave a Comment